Latest filings (excl ownership)
15-12G
Securities registration termination
29 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 24
AW
Withdrawal of amendment
21 Mar 24
AW
Withdrawal of amendment
21 Mar 24
AW
Withdrawal of amendment
21 Mar 24
8-K
Termination of a Material Definitive Agreement
20 Mar 24
POS AM
Prospectus update (post-effective amendment)
18 Mar 24
POS AM
Prospectus update (post-effective amendment)
18 Mar 24
POS AM
Prospectus update (post-effective amendment)
18 Mar 24
25
Voluntary exchange delisting
18 Mar 24
EFFECT
Notice of effectiveness
14 Mar 24
POS AM
Prospectus update (post-effective amendment)
12 Mar 24
8-K
Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
7 Mar 24
8-K
Departure of Directors or Certain Officers
27 Dec 23
8-K
Departure of Directors or Certain Officers
7 Dec 23
8-K
Departure of Directors or Certain Officers
5 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
17 Nov 23
10-Q
2023 Q3
Quarterly report
6 Nov 23
DEFM14A
Proxy related to merger
12 Oct 23
DEFA14A
Additional proxy soliciting materials
12 Oct 23
8-K
Other Events
12 Oct 23
8-K
Entry into a Material Definitive Agreement
5 Oct 23
PREM14A
Preliminary proxy related to merger
2 Oct 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
DEFA14A
Additional proxy soliciting materials
30 Jun 23
8-K
Cyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and Dissolution
30 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 23
8-K
Other Events
5 Jun 23
8-K
Departure of Directors or Certain Officers
2 Jun 23
8-K
Departure of Directors or Certain Officers
31 May 23
10-Q
2023 Q1
Quarterly report
10 May 23
8-K
Cyteir Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights
10 May 23
UPLOAD
Letter from SEC
4 May 23
CORRESP
Correspondence with SEC
2 May 23
UPLOAD
Letter from SEC
1 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
DEFA14A
Additional proxy soliciting materials
27 Apr 23
Latest ownership filings
4
Braden Michael Leonard
25 Mar 24
SC 13G/A
BML Investment Partners, L.P.
19 Mar 24
4
Braden Michael Leonard
19 Mar 24
3
Braden Michael Leonard
19 Mar 24
SC 13D/A
GAMCO INVESTORS, INC. ET AL
12 Mar 24
4
David G Gaiero
5 Mar 24
4
MARKUS MD RENSCHLER
5 Mar 24
4
Jean George
16 Feb 24
SC 13G/A
Lightstone Ventures II, L.P.
14 Feb 24
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 24
SC 13G
Newtyn Management, LLC
14 Feb 24
4
Stephen H. Sands
14 Feb 24
SC 13G/A
Avidity Partners Management LP
13 Feb 24
4
JOHN F THERO
12 Feb 24
SC 13D/A
GAMCO INVESTORS, INC. ET AL
9 Feb 24
4
Joseph S Zakrzewski
8 Feb 24
SC 13G/A
BML Investment Partners, L.P.
7 Feb 24
SC 13G/A
HEDGEHOG CAPITAL LLC
19 Jan 24
4
David G Gaiero
14 Dec 23
4
MARKUS MD RENSCHLER
14 Dec 23
4
MARKUS MD RENSCHLER
22 Nov 23
4
David G Gaiero
22 Nov 23
SC 13G
HEDGEHOG CAPITAL LLC
3 Nov 23
SC 13D
GAMCO INVESTORS, INC. ET AL
19 Oct 23
SC 13D/A
Novo Holdings A/S
3 Aug 23
SC 13D/A
Novo Holdings A/S
26 Jul 23
4
Change in insider ownership
20 Jul 23
4
Change in insider ownership
18 Jul 23
144
Notice of proposed sale of securities
14 Jul 23
SC 13G/A
FMR LLC
10 Jul 23
4
Change in insider ownership
3 Jul 23
144
Notice of proposed sale of securities
30 Jun 23
4
Change in insider ownership
28 Jun 23
144
Notice of proposed sale of securities
28 Jun 23
4
Change in insider ownership
23 Jun 23
4
Change in insider ownership
20 Jun 23
4
Change in insider ownership
14 Jun 23
144
Notice of proposed sale of securities
12 Jun 23
SC 13G
BAKER BROS. ADVISORS LP
14 Feb 23
SC 13G/A
Avidity Partners Management LP
14 Feb 23